CAS RN: 1032570-69-6
8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.05g, 0.1g, 0.25g, 1g, 5g
- Available purity: ≥95%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1032570-69-6
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.05g |
≥95% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.1g |
≥95% |
5
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
≥95% |
5
In Stock
|
Shanghai |
Inquiry |
| 1g |
≥95% |
5
In Stock
|
Beijing |
Inquiry |
| 5g |
≥95% |
5
In Stock
|
Shanghai |
Inquiry |
1032570-69-6 / 7-methoxy-8-phenylmethoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-imine
5-Amino-8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazoline | 8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine | MFCD32690930
Standard CAS: 1032570-69-6
Multi CAS: No
Basic Information
CAS
1032570-69-6
Multi CAS
No
Molecular Formula
C18H18N4O2
Molecular Weight
322.400000
Exact Mass
322.142976
SMILES
COC1=C(C=CC2=C3NCCN3C(=N)N=C21)OCC4=CC=CC=C4
InChI
InChI=1S/C18H18N4O2/c1-23-16-14(24-11-12-5-3-2-4-6-12)8-7-13-15(16)21-18(19)22-10-9-20-17(13)22/h2-8,19-20H,9-11H2,1H3
InChIKey
SMFREDPRQREFOX-UHFFFAOYSA-N
Synonyms
5-Amino-8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazoline
8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine
MFCD32690930
starbld0003046
SCHEMBL1655758
Computed Properties
Structural Parameters
Heavy atom count
24
Aromatic heavy atom count
16
Fraction Csp3
0.22
Rotatable bonds
4
H-bond acceptors
6
H-bond donors
2
Molar refractivity
91.4
TPSA
72.16
LogP / Solubility
WLOGP
2.53
MLOGP
2.24
XLogP3
2.2
Consensus LogP
2.32
Log S (ESOL)
-3.66
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.03
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.33
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.89
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
3